Gyn Obs Flashcards
(97 cards)
On a midline sagittal T2W MR image of the uterus of a 25-year-old female, the endometrium, junctional zone and outer myometrium of the corpus are clearly identified. From innermost to outermost, which of the following signal intensities best describes the normal uterus? [B4 Q89]
a. high, intermediate, low
b. high, low, intermediate
c. intermediate, high, low
d. intermediate, low, high
e. low, intermediate, high
b. high, low, intermediate
The premenopausal uterus normally has a bright endometrium within a dark junctional zone and an intermediate outer myometrium on T2W images. Cancer disrupts the zonal anatomy seen on T2W MRI. T1W sequences do not demonstrate uterine zonal anatomy.
On T2W images, the uterine cervix has a distinct zonal signal pattern that is particularly well seen on sequences acquired perpendicular to the long axis of the cervix. These are especially useful for cervical cancer staging.
The cervix lumen is bright
The cervical mucosa is intermediate to bright.
The fibromuscular cervical stroma is dark
The cervical stroma (outer layer) is intermediate
With age or radiation treatment, the uterus involutes and loses this zonal appearance on T2W MRI.
Regarding normal pelvic floor anatomy, which of the following is contained within the middle compartment of the female pelvic floor? [B4 Q91]
a. bladder
b. urethra
c. vagina
d. rectum
e. anus
c. vagina
The pelvic floor is supported by the endopelvic fascia and the levator ani muscle complex. This complex consists of three muscle groups: iliococcygeal, pubococcygeal, and puborectalis. The anterior compartment of the female pelvic floor contains the bladder and urethra. The middle compartment contains the vagina, and the posterior compartment contains the rectum.
A 25-year-old woman with a history of pelvic pain undergoes a transvaginal ultrasound examination. The endometrium is 15 mm thick. Which phase of the menstrual cycle is the patient in? [B5 Q10]
a. Proliferative phase
b. Day 7 after menstruation
c. Follicular phase
d. Luteal phase
e. Day 15 of the cycle
d. Luteal phase
Endometrial thickness:
- Immediately after menstruation: 1–4 mm thick.
- Proliferative phase: 7–10 mm.
- Follicular phase: 8–12 mm
- Luteal phase: 8–16 mm and becomes echogenic throughout.
A 14-year-old female presents with a history of cyclic pelvic pain. Speculum vaginal examination reveals a bulging vaginal mass. An MRI of the pelvis demonstrates divergent uterine horns with a deep midline fundal cleft, two separate uterine cavities, two separate cervices, and a unilateral hemivaginal septum causing hematometrocolpos. There is associated renal agenesis on the side of the hemivaginal septum. What is the primary uterine anomaly?
a. Uterus didelphys
b. Uterine bicornuate bicollis
c. Septate uterus
d. Arcuate uterus
e. Imperforate hymen
a. Uterus didelphys
Uterus didelphys is caused by complete failure of fusion of the paramesonephric ducts, resulting in a completely duplicated system (two uterine cavities and two cervices) with no communication between the two cavities. It is associated with complete or partial vaginal septum in 75% of cases, which can result in obstruction and haematometrocolpos. Ipsilateral renal agenesis is associated with a vaginal septum.
A 13-year-old girl presents with lower abdominal pain. She says she has had it intermittently for over a year. She has not yet had a period. On ultrasound examination the uterus is displaced cranially by a large cystic mass in the region of the vagina. It contains a large quantity of echogenic fluid, and a fluid-debris level is visible. The bladder is not visualised. What is the most likely diagnosis? [B2 Q49]
a. Duplication cyst
b. Rectovesical fistula
c. Haematocolpos
d. Hydrometra
e. Cloacal malformation
c. Haematocolpos
Haematocolpos is the accumulation of blood within the vagina and is typically caused by an imperforated hymen. This causes acute-on-chronic lower abdominal/pelvic pain as menstrual blood is prevented from normal discharge (apparent lack of menstruation). Ultrasound reveals an echogenic cystic mass with or without fluid-debris levels in the region of the vagina. The distended vagina often causes displacement of the uterus and compression of the bladder so that the latter may not be visualised.
MRI shows two separate normal-sized uteri and cervices with a septum extending into the upper vagina. The two uteri are widely separated, with preservation of the endometrial and myometrial widths. What name is given to this abnormality? [B3 Q40]
a. Uterus didelphys
b. Mullerian agenesis
c. Unicornuate uterus
d. Uterus bicornuate
e. Septate uterus
a. Uterus didelphys
When partial fusion of the Müllerian ducts occurs, myometrium forms the dividing septum. This abnormality is known as a bicornuate uterus. A septate uterus arises when there is only partial resorption of the final fibrous septum dividing the two horns of the uterus. The latter defect results in further reproductive complications.
A 17-year-old female with primary amenorrhoea is found on clinical examination to have a hypoplastic upper/middle vagina. MRI shows an absent uterus but normal tubes and ovaries. Which of the following is the most likely diagnosis? [B4 Q70]
a. uterus didelphys
b. unicornuate uterus
c. Mayer–Rokitansky–Kuster–Hauser syndrome
d. uterine agenesis
e. septate uterus
c. Mayer–Rokitansky–Kuster–Hauser syndrome
The uterus, fallopian tubes, and upper vagina arise from the paired paramesonephric (müllerian) ducts. The caudal parts fuse and ultimately form the uterus and upper vagina with resorption of the midline septum. The cranial parts remain unfused and form the fallopian tubes. Congenital uterine abnormalities arise with failure of development or fusion of this duct, or failure of midline resorption following fusion. Mayer–Rokitansky–Küster–Hauser syndrome describes uterine agenesis accompanied by hypoplastic proximal/middle third of the vagina but normal tubes and ovaries. Forty percent of patients with the syndrome have pelvic kidneys and other urinary tract anomalies are also associated.
A 48-year-old woman undergoes investigation for postmenopausal bleeding. Ultrasound shows a hyperechoic endometrial mass which contains several small cystic spaces. Power Doppler reveals a vessel at its base. On T2-weighted MR imaging the mass contains a central fibrous core with low signal intensity and small, well delineated cysts showing marked high signal intensity. The central core enhances post-contrast administration. The junctional zone is intact. What is the most likely diagnosis? [B1 Q15]
a. Endometrial hyperplasia
b. Submucosal leiomyoma
c. Submucosal fibroid
d. Adenomyoma
e. Endometrial polyp
Endometrial polyp
Endometrial polyps are common benign tumours of the endometrial cavity. They are most common after the age of 40 years and are rare before menarche. Typical ultrasound appearance is of a hyperechoic endometrial mass which may or may not contain cystic spaces. A feeding vessel is often demonstrated from the base on power Doppler. (Submucosal fibroids are generally of reduced echogenicity).
On MRI, a mass which contains a central fibrous core that enhances post-contrast and also contains well-demarcated T2-hyperintense cysts suggests endometrial polyp. An intact junctional zone and smooth tumour-myometrium interface also favour a polyp.
A 43-year-old woman with a history of breast carcinoma undergoes a CT of abdomen for abdominal pain and menorrhagia. This reveals an enlarged uterus, and she proceeds to MRI. The normal T2WI zonal anatomy of the uterus is preserved. The endometrial stripe is of high T2WI signal and measures 14 mm in diameter, and the myometrium is thickened. Lattice-like enhancement of the high-signal T2WI endometrial area is demonstrated on T1WI post contrast administration. There is no evidence of myometrial invasion. What is the diagnosis most consistent with these findings? [B1 Q61]
a. Intrauterine contraceptive device (IUCD)
b. Tamoxifen therapy
c. Lymphoma of the uterus
d. Endometrial stromal sarcoma
e. Pelvic congestion syndrome
Tamoxifen therapy
The normal endometrial stripe is of high T2WI signal and measures 3–6 mm in diameter in the follicular phase and 5–13 mm in the secretory phase. The description of the endometrium in this case is consistent with endometrial hyperplasia, but there is in addition myometrial enlargement. An enlarged uterus is frequently encountered in the presence of endogenous or exogenous hormonal abnormalities. In these cases, the uterus usually has normal zonal anatomy, although the signal intensity of the endometrium and myometrium is abnormally increased. However, with tamoxifen, the uterus can display marked zonal anatomy distortion. It is a weak oestrogen agonist and can result in endometrial hyperplasia, polyps, and carcinoma. The findings of multiple cysts or lattice-like enhancement of the endometrium post contrast are encountered frequently in relation to tamoxifen therapy and favour a benign diagnosis.
A female undergoes transvaginal ultrasound for postmenopausal bleeding. In which of the following situations can you virtually exclude the presence of endometrial cancer? [B2 Q50]
a. An endometrial thickness of 5 mm in a patient who has never undergone hormone replacement therapy (HRT)
b. An endometrial thickness of 6 mm in a patient using sequential combined HRT
c. An endometrial thickness of 5 mm in a patient using continuous combined HRT
d. An endometrial thickness of 4 mm in a patient using sequential combined HRT
e. An endometrial thickness of 4 mm in a patient who has not used any form of HRT for one year or more
An endometrial thickness of 4 mm in a patient who has not used any form of HRT for one year or more
An endometrial thickness of 3 mm can be used to exclude endometrial cancer in women who:
1. Have never used HRT, or
2. Have not used any form of HRT for one year, or
3. Are using continuous combined HRT.
In the above conditions, the post-test risk of a patient having endometrial cancer is 0.6–0.8% when the endometrial thickness is 3 mm but 20–22% when the endometrial thickness is >3 mm.
An endometrial thickness of 5 mm can be used to exclude endometrial cancer in women using sequential combined HRT (or having used it within the past year). In this scenario, the post-test risk of a patient having endometrial cancer is 0.1–0.2% when the endometrial thickness is 5 mm but 2–5% when the endometrial thickness is >5 mm.
A transvaginal ultrasound scan is performed on a premenopausal woman on day 21 of the menstrual cycle. Given that her endometrium is normal, which of the following measurements of endometrial thickness is most likely? [B4 Q65]
a. 2 mm
b. 2–4 mm
c. 4–8 mm
d. 7–14 mm
e. greater than 14 mm
7–14 mm
The menstrual endometrium is under 4 mm. After menstruation and up to day 14, the proliferative endometrium is 4–8 mm. Days 14–28 are secretory with the endometrium 7–14 mm. On ultrasound scan, the endometrium is seen as an echo-bright stripe. Unless the patient is taking tamoxifen or hormones, the postmenopausal endometrium should be less than 4 mm. A cut-off of 3 mm when performing screening for endometrial cancer has a 99% negative predictive value.
A postmenopausal woman is found on MRI to have a multicystic adnexal mass that contains fluid–fluid levels and does not show any fat suppression. In addition, her uterus shows a widened junctional zone containing small bright foci on T2W images. For which of the following diseases is she most likely to be receiving oral treatment that can account for these findings? [B4 Q72]
a. urinary tract infection
b. deep venous thrombosis
c. endometrial cancer
d. breast cancer
e. bipolar disorder
Breast cancer
The patient is receiving tamoxifen. Side effects include subendometrial cysts, endometrial hyperplasia, and endometrial polyps. Less frequent side effects are endometriosis, polypoid endometriosis, adenomyosis and cervical polyps. There is an increased risk of endometrial carcinoma.
On MRI, an endometrioma can appear as a multicystic adnexal mass of high T1 - (blood) and both hypointense on T2 signal (iron - T2 Shading), but without the fat suppression that would be expected with a mature cystic teratoma.
Adenomyosis on MRI may manifest as a uterus with a thickened, low-signal, junctional zone on T2W images, containing small foci of high T2 signal.
45-year-old woman presents with menorrhagia and dysmenorrhea. She has had three successful pregnancies and one therapeutic abortion in the past. She undergoes an MRI of the pelvis 14 days after the start of her last menstrual period. It reveals a junctional zone which measures 13 mm throughout, with hyperintense T2WI foci within it. With what conditions are these findings most consistent? [B1 Q2]
a. Endometrial hyperplasia.
b. Endometrial carcinoma stage 1A.
c. Pseudothickening.
d. Adenomyosis
e. Myometrial contraction
Adenomyosis
Adenomyosis appears as focal or diffuse thickening of the junctional zone of 12 mm or greater. Thickening of 8–12 mm is indeterminate, while thickening less than 8 mm usually allows exclusion of the disease. The bright foci on T2WI correspond to islands of ectopic endometrial tissue and cystic dilatation of glands and have been reported to be present in up to 50% of cases of adenomyosis. Occasionally haemorrhage within these areas of ectopic endometrial tissue can result in areas of high signal within the junctional zone on T1WI.
A 30-year-old female patient with a history of infertility is referred for an HSG. She has a past history of pelvic inflammatory disease. HSG reveals multiple small outpouchings from the uterine cavity. What is the diagnosis? [B1 Q68]
a. Salpingitis isthmica nodosa
b. Asherman syndrome
c. Adenomyosis
d. Endometritis
e. Multiple endometrial polyps
Adenomyosis
This is a condition in which the endometrium extends into the myometrium in either a diffuse or a focal distribution. It generally manifests as pelvic pain or abnormal bleeding. It is more commonly detected on MR imaging as thickening of the junctional zone >12mm or on ultrasound as diffuse or focal heterogenous myometrium. On HSG, adenomyosis appears as small diverticula extending from the endometrial cavity into the myometrium.
A 70-year-old woman is known to have uterine fibroids. There has been a clinically apparent increase in the uterine size. Transvaginal ultrasound appearances are in keeping with a large myometrial fibroid. Which of the following diagnoses must be considered in this patient? [B4 Q76]
a. lipo-leiomyoma
b. endometrial hyperplasia
c. adenomyoma
d. leiomyosarcoma
e. Bartholin’s gland tumour
Leiomyosarcoma
Uterine fibroids are estrogen-dependent and should involute following menopause. Increase in the size of a fibroid after menopause should raise the possibility of sarcomatous degeneration. On ultrasound scan, the appearance of leiomyosarcoma may be indistinguishable from that of a benign fibroid.
Involvement of which of the following indicates the poorest prognosis in recurrent endometrial cancer? [B3 Q18]
A. Vagina
B. Spleen
C. Lung
D. Bladder
E. Well-differentiated tumour at original surgery
Spleen
Splenic, liver, and multiple sites of disease are independent predictors of poor outcome.
Regarding endometrial carcinoma on MR: [B3 Q36]
A. Normal zonal anatomy is best demonstrated on T1
B. Tumour is typically higher signal compared with endometrial lining on T2
C. Tumour is typically higher signal intensity than myometrium
D. Enhances faster than myometrium on dynamic contrast enhancement
E. Usually low SI than brightly enhancing normal myometrial tissue after contrast
Usually low SI than brightly enhancing normal myometrial tissue after contrast
Endometrial tumours are usually isointense to myometrium on T1 and lower SI to endometrial lining on T2. Tumours demonstrate slower enhancement on DCE than myometrium. Normal zonal anatomy is clearly depicted on T2.
A patient with endometrial cancer previously treated with surgery has an 18 FDG PET scan to look for recurrence. A false-negative result could be caused by which of the following scenarios? [B4 Q35]
a. peritoneal deposits smaller than 1 cm
b. bladder diverticulum
c. post-surgical inflammation
d. abscess
e. bowel avidity
Peritoneal deposits smaller than 1 cm
False positives can occur with PET because 18 FDG is a metabolic tracer, and activity is seen in normal bowel, ovaries (cyclical), endometrium (cyclical), blood vessels, bone marrow, and skeletal muscle. 18 FDG is renally excreted; hence, focal accumulation can be seen in ureters, bladder diverticula, pelvic kidneys, and urinary diversions. Benign processes can also take up this tracer, including abscesses, uterine fibroids, endometriosis, post-surgical inflammation, post-radiotherapy inflammation, and sacral fractures. False-negative PET scans can be caused by small tumour deposits close to the urinary bladder, where they cannot be resolved from each other.
A 79-year-old female has a 6-month history of vaginal bleeding. Transvaginal ultrasound scan demonstrates an ill-defined endometrium measuring 20 mm in thickness. Outpatient clinic endometrial biopsy confirms endometrial adenocarcinoma. MRI stage is T4. Which of the following MRI features supports this stage? [B4 Q86]
a. disease limited to the endometrium
b. cancer invasion evident into the outer half of the myometrium
c. vaginal involvement
d. rectal serosal involvement
e. bladder mucosal involvement
Bladder mucosal involvement
Endometrial carcinoma becomes stage T4 when bladder or bowel mucosa is involved, whereas the stage remains T3 if other layers of bowel or bladder are invaded.
On MRI, endometrial carcinoma has homogeneous signal intensity, isointense to myometrium on T1W images, and hypointense to endometrial lining on T2W images. Endometrial cancers demonstrate slower contrast enhancement to a lower peak of enhancement than normal myometrium.
A 65-year-old diabetic woman presents with bleeding per vagina. Ultrasound shows echogenic and irregular endometrium measuring 12 mm in thickness. What is the most likely diagnosis? [B5 Q12]
a. Submucosal fibroid
b. Endometrial polyp
c. Endometrial carcinoma
d. Endometrial sarcoma
e. Uterine sarcoma
Endometrial carcinoma
Endometrial carcinoma is the fourth most common female cancer, with a peak between 55 and 65 years. In postmenopausal women, endometrial thickness more than 5 mm should be investigated for endometrial carcinoma. Sarcomas are rare in this age group.
A 36-year-old woman with a history of previous miscarriage treated by evacuation of retained products of conception, presents with amenorrhea. Hysterosalpingography shows multiple, irregular, constant filling defects in the uterine cavity which cannot be obscured by contrast filling into the uterine cavity. What is the most likely diagnosis? [B5 Q15]
a. Adenomyosis
b. Submucosal fibroids in uterus
c. Polyps
d. Asherman’s syndrome
e. Subserosal uterine fibroids
Asherman’s syndrome
Synechiae or intrauterine adhesions were described by Asherman and are usually a result of uterine curettage or evacuation of retained products of conception. The hysterosalpingogram findings are diagnostic.
A 37-year-old woman presents with a watery vaginal discharge and attends for an MRI of pelvis. She becomes quite claustrophobic at the end of the scan, and you are called to assess her as she has been hyperventilating and the radiographers have become concerned. As you reassure her, you notice some peri-oral pigmentation. The MRI reveals a multi-cystic lesion (high T2WI and low T1WI signal) in the uterine cervix with a solid (low signal T1WI and T2WI) component in the deep cervical stroma. You note from the picture archiving and communication system (PACS) system that a barium enema previously revealed several colonic polyps. What is the likely cause for the MRI findings? [B1 Q66]
A. Malignant melanoma of the cervix.
B. Carcinoid tumour of the cervix.
C. Cervical pregnancy.
D. Minimal deviation adenocarcinoma of the cervix.
E. Invasive cervical squamous cell carcinoma.
Minimal deviation adenocarcinoma of the cervix.
This is also known as adenoma malignum and, as in this scenario, is often associated with Peutz Jeghers syndrome (characterized by mucocutaneous pigmentation, multiple hamartomatous polyps of the GI tract, and mucinous tumours of the ovary). Adenoma malignum makes up about 3% of adenocarcinoma of the cervix. Its MRI appearances are as described in the question, but the differential diagnosis includes deep nabothian cysts, florid endocervical hyperplasia, and even well-differentiated adenocarcinoma. It disseminates into the peritoneal cavity even in the early stage of the disease and its response to radiation or chemotherapy is poor.
Cervical squamous carcinoma makes up to 90% of cervical carcinoma. The tumour is of high signal compared to the hypointense cervical stroma, but not cystic as in our vignette. It advances predominantly by direct extension and local spread; haematogenous dissemination is only occasionally seen in the form of hepatic metastases.
Carcinoid tumour of the cervix is a subgroup of small cell carcinoma of the cervix. It cannot be differentiated from squamous cell carcinoma of the cervix on MRI findings.
Malignant melanoma of the female genital tract accounts for 1–5% of all melanomas. It usually occurs in the vaginal mucosa and occasionally involves the cervix. Malignant melanoma arising in the cervix is very rare (only about 30 reported cases). There is usually high signal intensity on T1WI.
The incidence of cervical pregnancy has been increasing, possibly due to the increased number of induced abortions. Reported risk factors include multiparity, prior cervical surgical manipulation, cervical or uterine leiomyomas, atrophic endometrium, and septate uterus. The major symptom is painless vaginal bleeding. At MR it is characterized by a mass with heterogeneous signal intensity and a partial or complete dark ring on T2WI sequences. As it contains haematoma, it often consists of some high signal on T1WI.
A 48-year-old woman presents with shortness of breath and undergoes an HRCT of the chest to assess interstitial changes seen on plain film. She has emigrated from Eastern Europe and knows that she had a gynaecological cancer that was treated there but is unsure of her treatment. The HRCT reveals unilateral thickened interlobular septa, peri-lymphatic nodules, and ipsilateral hilar adenopathy. What is the most likely underlying diagnosis? [B1 Q67]
A. Cervical carcinoma.
B. Ovarian epithelial carcinoma.
C. Endometrial carcinoma.
D. Leiomyosarcoma of the uterus.
E. Vaginal carcinoma.
Cervical carcinoma.
This patient has developed lymphangitis carcinomatosis. In 50% of cases the septal thickening is focal or unilateral and this is useful in distinguishing lymphangitis from other causes of septal thickening, such as pulmonary oedema or sarcoidosis. Hilar adenopathy is present in 50% and pleural effusion in 30–50%. The interlobular septal thickening can be smooth (as in pulmonary oedema and alveolar proteinosis) or nodular (also found in sarcoidosis and silicosis).
Lymphangitis carcinomatosis usually occurs secondary to the spread of (adeno-) carcinoma, most commonly bronchogenic, breast, and stomach. The mnemonic Certain Cancers Spread By Plugging The Lymphatics (Cervix Colon Stomach Breast Pancreas Thyroid Larynx) is useful. Lymphangitis carcinomatosis is occasionally associated with cervical carcinoma and certainly more so than with the other options presented.
A 42-year-old woman presents with post-coital bleeding. Transvaginal ultrasound shows the cervix to be enlarged, irregular and hypoechoic. MRI demonstrates a large cervical cancer with involvement of multiple pelvic lymph nodes. The left kidney is hydronephrotic. What is the most appropriate staging based on these findings? [B2 Q2]
a. T1
b. T2b
c. T3
d. T3b
e. T4
T3b
Cervical neoplasms are staged according to the TNM/FIGO classification. Stage I tumours are confined to the uterus. In stage IIA, there is involvement of the upper two-thirds of the vagina. Stage IIB shows parametrial invasion without pelvic sidewall involvement. Stage IIIA demonstrates invasion into the lower third of the vagina, and IIIB includes pelvic sidewall invasion with or without hydronephrosis. Tumour invasion into the bladder and rectal mucosa or distant metastasis accounts for stage IV disease. Pelvic nodal metastases do not alter the FIGO stage but para-aortic or inguinal node metastases are classified as stage IVB